How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
about
Model Comparison for Breast Cancer Prognosis Based on Clinical Data.Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrationsThe impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.Analysing population-based cancer survival - settling the controversies.Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway.Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis.Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes.
P2860
Q31037110-9498231F-678C-4575-B6FD-ED87EBC2B76AQ34465110-68F3462E-104D-4321-9B52-B8E82C7705FEQ35832484-E6A6185E-6A09-4558-ADC2-705FCC9AF4B6Q36212210-67F92F0B-705D-44DA-A6A4-6D7530EC0700Q37589084-C4E44752-C6C9-42B4-944A-B6A7A6E439BCQ38736557-451506A2-A8EB-40D2-9250-A76416BAA449Q39372883-2330B1BD-F77A-4C9F-9AA2-BE771ECF5A5AQ40382175-0C60985C-152C-4A99-A817-D88E565533C0Q44628624-7E274CC4-1D7B-423B-B57C-AD88EECD9893Q45283058-025274A4-56D2-4111-84C1-C7B4E655C675Q45390612-CB68FA7E-2FFD-41B9-A50C-445A6242123EQ52820972-C7D56F64-385F-484F-BCD1-409416426FFE
P2860
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@en
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@nl
type
label
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@en
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@nl
prefLabel
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@en
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@nl
P2093
P2860
P50
P1476
How can we make cancer surviva ...... zed prostate cancer in Sweden.
@en
P2093
Pär Stattin
Sandra Eloranta
P2860
P2888
P304
P356
10.1007/S10552-012-0141-5
P577
2013-01-08T00:00:00Z
P6179
1019972455